Shares of Beta Bionics (Nasdaq:BBNX) experienced a rise in after-hours trading following the release of its fourth-quarter results. The company’s financial performance exceeded the consensus sales forecast, leading to a nearly 2% increase in share price, reaching $15.50 during post-market trading.
This report marks the company’s inaugural quarterly earnings announcement since its public debut through a $234.6 million IPO in January.
Recent advancements for Beta Bionics include the introduction of the Color iLet system, which features a color screen and a brighter display. Furthermore, the company achieved a market first by integrating the iLet with the Abbott FreeStyle Libre 3 Plus in the U.S. during the fourth quarter.
